| 0 (0%) | 09-27 14:45 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 123.13 | 1-year : | 134.19 |
| Resists | First : | 105.42 | Second : | 114.88 |
| Pivot price | 99.16  |
|||
| Supports | First : | 90.12 | Second : | 74.97 |
| MAs | MA(5) : | 98.58  |
MA(20) : | 100.22 |
| MA(100) : | 105.24 |
MA(250) : | 108.66 |
|
| MACD | MACD : | -2.5 |
Signal : | -2.6 |
| %K %D | K(14,3) : | 36.1 |
D(3) : | 35.4 |
| RSI | RSI(14): 42.7 | |||
| 52-week | High : | 129.27 | Low : | 81.19 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ BNTX ] has closed above bottom band by 38.2%. Bollinger Bands are 36% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 98.67 - 99.15 | 99.15 - 99.56 |
| Low: | 95.8 - 96.35 | 96.35 - 96.83 |
| Close: | 97.25 - 98.11 | 98.11 - 98.85 |
Tue, 23 Sep 2025
BioNTech SE - American Depositary Shares (NQ: - FinancialContent
Tue, 23 Sep 2025
Will Easier Access to COVID Vaccines Shift BioNTech's (BNTX) Revenue and Market Narrative? - simplywall.st
Tue, 23 Sep 2025
FNDF, FERG, BNTX, APTV: Large Inflows Detected at ETF - Nasdaq
Tue, 23 Sep 2025
BMO Capital Maintains a Buy on BioNTech SE (BNTX) - MSN
Tue, 23 Sep 2025
AI in Biotech: BioNTech's Second Innovation Day to Showcase AI Strategy and Drug Development Pipeline - Stock Titan
Mon, 22 Sep 2025
New Analyst Forecast: $BNTX Given $121.0 Price Target - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 240 (M) |
| Shares Float | 94 (M) |
| Held by Insiders | 62.6 (%) |
| Held by Institutions | 23.1 (%) |
| Shares Short | 6,020 (K) |
| Shares Short P.Month | 6,050 (K) |
| EPS | -1.7 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 76.98 |
| Profit Margin | -12 % |
| Operating Margin | -167.5 % |
| Return on Assets (ttm) | -2.2 % |
| Return on Equity (ttm) | -1.9 % |
| Qtrly Rev. Growth | 102.5 % |
| Gross Profit (p.s.) | 9.56 |
| Sales Per Share | 11.98 |
| EBITDA (p.s.) | -2.06 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1,740 (M) |
| Levered Free Cash Flow | -2,390 (M) |
| PE Ratio | -58.04 |
| PEG Ratio | 0 |
| Price to Book value | 1.27 |
| Price to Sales | 8.18 |
| Price to Cash Flow | -13.56 |
| Dividend | 2.1 |
| Forward Dividend | 0 |
| Dividend Yield | 2.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|